跳至主要内容
临床试验/NCT05266651
NCT05266651Unknown2 期

Efficiency of Tadalafil for Management of Female Sexual Dysfunction in Females With Genital Mutilation

Kasr El Aini Hospital1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2022年3月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
24
试验地点
1
主要终点
clitorial Artery Doppler

研究概览

简要总结

comparative study between tadalafil versus placebo effect for the management of circumsized female

详细描述

the group of patient will be randomly divided into 2 groups, half of the patients will receive tadalafil and the other half will receive placebo

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
25 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • female with history of female genital mutilation female with history of sexual dysfunction

排除标准

  • any medical disorder

研究组 & 干预措施

tadalafil group

Active Comparator

5 mg of Tadalafil on daily bases for one month duration

干预措施: Tadalafil 5mg (Drug)

placebo group

Placebo Comparator

the patients will receive oral tablets without any active substance for one month

干预措施: Placebo (Drug)

结局指标

主要结局

clitorial Artery Doppler

时间窗: after one month duration of drug use

Pulsatile index

Clitorial artery doppler

时间窗: after one month duration of drug use

Peak systolic velosity

次要结局

  • score of sexual function(after on month of the drug use)

研究者

发起方
Kasr El Aini Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hussein Aly Hussein

Assistant professor

Kasr El Aini Hospital

研究点 (1)

Loading locations...

相似试验